Repaglinide-d5

• Description :

  Repaglinide-d5 is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].

• CAS Number :

  [1217709-85-7]

• Product Name Alternative :

  AG-EE 623ZW D5

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Isotope-Labeled Compounds; Potassium Channel

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  Membrane Transporter/Ion Channel; Others

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Metabolic Disease

• Purity :

  98.67

• Solubility :

  DMSO : ≥ 50mg/mL

• Smiles :

  O=C(O)C1=CC=C(CC(N[C@H](C2=CC=CC=C2N3CCCCC3)CC(C)C)=O)C=C1OC([2H])([2H])C([2H])([2H])[2H]

• Molecular Formula :

  C27H31D5N2O4

• Molecular Weight :

  457.62

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus.Medicine (Baltimore) . 2018 Sep;97 (38) :e12476.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported